Press release
Multiomics Market Size, Product Trends, Key Drivers, Share Analysis And Forecast To 2033
"The new report published by The Business Research Company, titled ""Multiomics Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.As per the report, the multiomics market size has grown rapidly in recent years. It will grow from $2.78 billion in 2023 to $3.27 billion in 2024 at a compound annual growth rate (CAGR) of 17.7%. The multiomics market size is expected to see rapid growth in the next few years. It will grow to $6.28 billion in 2028 at a compound annual growth rate (CAGR) of 17.8%.
Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15866&type=smp
Rising Demand For Personalized Medicine Fuels Growth Of The Multiomics Market
The rising demand for personalized medicine is expected to propel the growth of the multiomics market going forward. Personalized medicine refers to a medical approach that customizes healthcare decisions and treatments to individual patients based on their genetic, environmental, and lifestyle factors. This personalized medicine approach is rising due to technological advancements, increasing demand for targeted therapies, and global healthcare improvements. Multiomics helps personalized medicine by providing a detailed understanding of an individual's genetic, molecular, and metabolic profile, enabling healthcare providers to tailor treatments based on the specific characteristics of each patient. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to 6 in 2022. Therefore, the rising demand for personalized medicine is driving the growth of the multiomics market.
Innovative Single-Cell Multiomics Platforms Transforming Research
Major companies operating in the multiomics market are developing advanced single-cell multiomics platforms to enable scientists to run large-scale studies without sacrificing sample integrity. Single-cell multiomics platforms integrate various omics with artificial intelligence capabilities, allowing users to seamlessly analyze and interpret complex biological data through sophisticated algorithms and machine learning techniques. For instance, in February 2023, Becton, Dickinson, and Company, a US-based medical device company, launched the BD Rhapsody HT Xpress, a high-throughput single-cell multiomics platform. This innovative system enables scientists to isolate, barcode, and analyze single cells at a high sample throughput, accommodating up to eight times more cells than previous versions of BD single-cell analyzers. The BD Rhapsody HT Xpress System ensures no sample loss, offering flexibility to analyze multiple samples and different cell sizes and types simultaneously, such as stem cells or cancer cells, enhancing researchers' ability to gain more insights in less time.
The multiomics market covered in this report is segmented -
1) By Type: Single-Cell Multiomics, Bulk Multiomics
2) By Platform: Genomics, Transcriptomics, Proteomics, Metabolomics, Integrated Omics Platforms
3) By Application: Diagnostics, Drug Discovery And Development, Personalized Medicine, AgriGenomics, Other Applications
4) By End User: Academics And Research Organization, Pharmaceutical And Biotechnology Companies, Clinical research Organization, Other End-Users
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=15866&type=discount
Major companies operating in the multiomics market are Bayer AG, Thermo Fisher Scientific Inc., Novartis AG, Becton Dickinson and Company, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Shimadzu Corporation, Bruker Corporation, Bio-Techne, Azenta Life Sciences, 10x Genomics, Ginkgo Bioworks, Abcam limited, BioLegend, Oxford Nanopore Technologies Plc, Adaptive Biotechnologies, Pacific Biosciences, Standard BioTools, Parse Biosciences, Mission Bio, CD Genomics, Singleron Biotechnologies, Psomagen, BGI Group
Contents of the report:
1. Executive Summary
2. Multiomics Market Report Structure
3. Multiomics Market Trends And Strategies
4. Multiomics Market - Macro Economic Scenario
5. Multiomics Market Size And Growth
…..
27. Multiomics Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/multiomics-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Multiomics Market Size, Product Trends, Key Drivers, Share Analysis And Forecast To 2033 here
News-ID: 3583476 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Multiomics
Multiomics Market to Hit USD 14.92 Billion by 2030
Multiomics Market to Hit USD 14.92 Billion by 2030 as Genomics, Proteomics & Metabolomics Converge to Transform Precision Medicine | Thermo Fisher, Illumina, Qiagen Lead the Global Landscape
Sub-Headline: The global Multiomics Market is projected to grow from USD 6.45 billion in 2023 to USD 14.92 billion by 2030, expanding at an impressive CAGR of 12.8%, driven by next-generation sequencing (NGS), AI-enabled analytics, and rising investments in precision medicine.
Introduction
The Multiomics Market…
Multiomics Market to Reach USD 17.8 Billion by 2034
In the era of precision medicine, understanding diseases at the molecular level is critical for developing effective diagnostics and therapies. Multiomics-the integration of multiple "omics" technologies such as genomics, transcriptomics, proteomics, metabolomics, and epigenomics-has become a transformative approach in biomedical research. By combining insights across these domains, researchers can build a holistic view of biological systems, identify biomarkers, and tailor treatments to individual patients.
Download Full PDF Sample Copy of Market…
Key Trends Influencing the Growth of the Multiomics Market in 2025: Innovative S …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Multiomics Market Through 2025?
The size of the multiomics market has seen swift expansion in the past few years. It is projected to rise from $3.27 billion in 2024, hitting $3.85 billion in 2025. This growth signifies a compound annual growth rate…
Growth Of Precision Medicine Boosts Single Cell Multiomics Market: A Key Driver …
The Single Cell Multiomics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Single Cell Multiomics Market Size and Its Estimated Growth Rate?
In recent times, the single cell multiomics market has experienced significant expansion. The anticipated growth will be from $3.97 billion…
Rising Demand For Personalized Medicine Fuels Growth Of The Multiomics Market: A …
The Multiomics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Multiomics Market Size and Projected Growth Rate?
The multiomics market has shown rapid growth in recent years. It will grow from $3.27 billion in 2024 to $3.85 billion in 2025 at a CAGR…
Growth Of Precision Medicine Boosts Single Cell Multiomics Market: Major Factor …
How Will the Single Cell Multiomics Market Grow, and What Is the Projected Market Size?
The market size for single cell multiomics has seen a tremendous expansion in recent years. The growth is expected to move from $3.97 billion in 2024 to $4.85 billion in 2025, marking an impressive Compound Annual Growth Rate (CAGR) of 22.1%. The exceptional growth during the historical period can be tied to factors such as the…
